These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3159214)

  • 1. Metabolic side effects of the platelet-inhibitory drug ticlopidine.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():281-3. PubMed ID: 3159214
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ticlopidine on platelet function and on coronary insufficiency in patients with angina pectoris.
    Berglund U; Wallentin L
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():277-80. PubMed ID: 3159213
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U; von Schenck H; Wallentin L
    Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombocytopenia due to antibodies induced by ticlopidine].
    Claas FH; de Fraiture WH; Meyboom RH
    Nouv Rev Fr Hematol (1978); 1984; 26(5):323-4. PubMed ID: 6504695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of platelet and leukocyte functions in effort angina patients using high shear conditions in small-sized collagen bead columns.
    Inami N; Nomura S; Kimura Y; Yamada K; Nakamori H; Takahashi N; Fukuhara S; Iwasaka T
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):428-31. PubMed ID: 17911196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris.
    de Maat MP; Arnold AE; van Buuren S; Wilson JH; Kluft C
    Thromb Haemost; 1996 Aug; 76(2):166-70. PubMed ID: 8865524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
    Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
    Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug.
    Labarthe B; Théroux P; Angioï M; Ghitescu M
    J Am Coll Cardiol; 2005 Aug; 46(4):638-45. PubMed ID: 16098428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease.
    Randi ML; Fabris F; Crociani ME; Battocchio F; Girolami A
    Arzneimittelforschung; 1985; 35(12):1847-9. PubMed ID: 4096744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB; Kjøller E; Skagen K; Gormsen J
    Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statins on platelet inhibition by a high loading dose of clopidogrel.
    Müller I; Besta F; Schulz C; Li Z; Massberg S; Gawaz M
    Circulation; 2003 Nov; 108(18):2195-7. PubMed ID: 14568892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impairement of the platelet lipid membrane composition in severe angina pectoris].
    Tulabaeva GM; Akhmedova NA
    Vopr Med Khim; 2002; 48(2):215-8. PubMed ID: 12189630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation induced by a human neuroblastoma tumor cell line is reduced by prior administration of ticlopidine.
    Bastida E; Escolar G; Almirall L; Ordinas A
    Thromb Haemost; 1986 Jun; 55(3):333-7. PubMed ID: 3750263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lipids in different forms of ischemic heart disease].
    Rymar B; Sikorska WK
    Wiad Lek; 1980 Nov; 33(22):1785-91. PubMed ID: 7210672
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol, platelets adhesiveness and fibrinolytic activity in ischaemic heart disease.
    Gupta KK
    J Assoc Physicians India; 1969 May; 17(5):323-31. PubMed ID: 5350177
    [No Abstract]   [Full Text] [Related]  

  • 16. Clopidogrel inhibits platelet aggregation in patients on aspirin with stable chronic angina pectoris.
    Saha S; Berglund M; Sylvén C; Gordon A; Agewall S
    Int J Cardiol; 2008 Jan; 123(2):195-6. PubMed ID: 17320208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
    Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Side effects of ticlopidine; clinical observation and immunological study].
    de Fraiture WH; Claas FH; Meyboom RH
    Ned Tijdschr Geneeskd; 1982 Jun; 126(23):1051-4. PubMed ID: 6213869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vitamin E and serum lipids in ischemic heart disease].
    Cherniauskene RCh; Margiavichene LE; Varshkiavichene ZZ; Gribauskas PS
    Vopr Med Khim; 1984; 30(3):102-5. PubMed ID: 6474933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.